Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yotaro Motomura
Observed name:
YOTARO MOTOMURA
Institution:
Institute of Science Tokyo
Observed institutions:
Tokyo Medical and Dental University,
National Center for Global Health and Medicine,
Ome Municipal General Hospital,
Institute of Science Tokyo Hospital,
Institute of Science Tokyo
ORCID:
0000-0002-1315-4936
Observed ORCID:
0000-0002-1315-4936
OpenAlex ID:
A5064934193
Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma
2024
·
Kota Yoshifuji
, Daichi Sadato
, et al.
·
Haematologica
·
14
Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment
2021
·
MAI KUBOKI
, YOSHIHIRO UMEZAWA
, et al.
·
In Vivo
·
14
PDF
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma
2023
·
Yotaro Motomura
, Kota Yoshifuji
, et al.
·
British Journal of Haematology
·
5
Dasatinib for chronic myelogenous leukemia improves skin symptoms of systemic sclerosis
2019
·
Kosuke Arai
, Kota Yoshifuji
, et al.
·
International Journal of Hematology
·
5
Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12
2022
·
Toshikage Nagao
, Kota Yoshifuji
, et al.
·
Experimental Hematology
·
4
PDF
Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma
2024
·
Yotaro Motomura
, Kota Yoshifuji
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
3
PDF
Efficacy and Safety of Balloon Kyphoplasty for Pathological Vertebral Fractures in Patients with Hematological Malignancies in Our Institution
2020
·
Keigo Okada
, Hiroki Fujiwara
, et al.
·
Internal Medicine
·
3
PDF
[Chronic myeloid leukemia harboring T315I and F317L mutations successfully treated with interferon-α and ponatinib].
2019
·
Yotaro Motomura
, Kosuke Arai
, et al.
·
PubMed
·
2
Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma
2025
·
Kota Yoshifuji
, Yotaro Motomura
, et al.
·
Blood Cancer Journal
·
1
PDF
Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma
2022
·
Yotaro Motomura
, Yoshihiro Umezawa
, et al.
·
Clinical Case Reports
·
1
PDF
Emerging BCR::ABL1 inhibitors in chronic myeloid leukemia: current advances and future directions
2026
·
Yotaro Motomura
, Koji Sasaki
·
International Journal of Hematology
[Improvement of extensive epidermolysis due to severe acute graft-versus-host disease through long-term multidisciplinary skin care].
2025
·
Fumihiko Ouchi
, Yotaro Motomura
, et al.
·
PubMed
TPL2, a New Prognostic Factor and a Potential Therapeutic Target in ABC-DLBCL
2022
·
Kota Yoshifuji
, Yotaro Motomura
, et al.
·
Blood
Clinical features of methotrexate-associated lymphoproliferative disorder: a single center analysis
2019
·
Yotaro Motomura
·
The Japanese Society of Hematology
Angioimmunoblastic T-cell Lymphoma Associated with Marked Polyclonal Plasmacytosis
2019
·
Sayaka Suzuki
, Rena Watanabe
, et al.
·
Nihon Naika Gakkai Zasshi
PDF
Prognostic factors of malignant lymphoma in elderly patients: A single center analysis
2018
·
Yotaro Motomura
·
The Japanese Society of Hematology
Double Autologous Stem Cell Transplantation Followed by Maintenance Therapy Conquers the Adverse Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Patients
2017
·
Yotaro Motomura
, Akiyoshi Miwa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
17
Citation count:
52
H-index:
4
I10-index:
2
Year
Topic
Type